ArticleScientific reports2025
Simple and rapid microfluidic device for processing raw human semen and separation of motile sperm based on their intrinsic behavior and morphology.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sperm separation is pivotal in Assisted Reproductive Technology to address male infertility issues such as low sperm concentration or impaired motility. Traditional microfluidic devices, despite their fair success, often fall short due to complex fabrication and use, or lack of direct sample extraction methods. Our research introduces a microfluidic device designed to enhance sperm quality, focusing on improved motility and morphology, while remaining simple to fabricate and use in infertility clinics. The device features four chambers interconnected by channels, engineered to establish low shear rate limits, facilitating high-quality sperm separation. Utilizing the principle of rheotaxis, where superior sperm swim against the flow, our system concentrates top-quality sperm in designated chambers. A key feature of the device is its ability to use raw semen, eliminating the need for pre-washing. Clinical trials with both washed human sperm samples and raw semen demonstrate the device's efficacy, achieving up to 100% sperm isolation and morphological improvements in under 5 min. This approach overcomes the throughput constraints of traditional microfluidic methods, leveraging rheotaxis, near-boundary swimming, and parallelization to increase selected sperm concentration. This advancement has the potential to substantially improve the effectiveness of fertility treatments, offering new hope to individuals facing conception challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.